Loading
Serum / Septic Shock / Sepsis · Interventional Study
ClinicalTrials.gov · August 4, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a prospective multicenter study registration designed to evaluate serum biomarkers of neuronal and glial injury as predictors of cognitive impairment in sepsis survivors. No results have been posted in this registry record; the study has not yet begun recruitment.
Interventional, Single Group, Open label, Diagnostic purpose. Sepsis, Septic Shock; age from 18 Years; to 80 Years. Intervention: Serum. n = 210. 1 site: France.
This is a prospective multicenter study registration designed to evaluate serum biomarkers of neuronal and glial injury as predictors of cognitive impairment in sepsis survivors. No results have been posted in this registry record; the study has not yet begun recruitment.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
When results become available, this study may clarify whether serum biomarkers of brain injury can predict cognitive sequelae in sepsis survivors and inform prognostication and monitoring strategies. Currently no clinical action is indicated from this registration alone.
This is a prospective multicenter trial registration with no results yet posted; enrollment has not begun and no outcome data are available.
As stated by the source record.
Quoted from the source exactly as published.
When results become available, this study may clarify whether serum biomarkers of brain injury can predict cognitive sequelae in sepsis survivors and inform prognostication and monitoring strategies. Currently no clinical action is indicated from this registration alone.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07746050). This is a study registration, not published results. Lead sponsor: Assistance Publique - Hôpitaux de Paris. Recruitment status: NOT_YET_RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 210 participants (ESTIMATED). Conditions: Sepsis, Septic Shock. Interventions: BIOLOGICAL: Serum. Primary outcome measures: Cognitive function impairment assessed by the Montreal Cognitive Assessment (MoCA) score at 3 months , 3 months. Brief summary: To evaluate the value of biomarkers of neuronal and glial injury for predicting cognitive impairment (memory impairment assessed by a MoCA score \< 26/30) at 3 months in patient admitted in the intensive care unit for a sepsis or a septic shock.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.